Bivalirudin: Package Insert / Prescribing Info - Drugs.com
2024年11月4日 · 250 mg of bivalirudin per 50 mL (5 mg/mL) in a single-dose vial. Ready-to-use. Each vial contains 250 mg of bivalirudin equivalent to an average of 275 mg bivalirudin trifluoroacetate*.
DailyMed - BIVALIRUDIN injection, solution
2024年10月29日 · 250 mg of bivalirudin per 50 mL (5 mg/mL) in a single-dose vial. Ready-to-use. Each vial contains 250 mg of bivalirudin equivalent to an average of 275 mg bivalirudin trifluoroacetate*.
Bivalirudin - StatPearls - NCBI Bookshelf
2024年2月28日 · Bivalirudin is a direct thrombin inhibitor (DTI) with specific actions indicated for intravenous (IV) anticoagulation in patients with acute myocardial infarction, unstable angina, percutaneous coronary intervention (PCI), and thrombosis in patients with a history of heparin-induced thrombocytopenia (HIT). [1] [2]
Bivalirudin is intended for intravenous bolus injection and continuous infusion after reconstitution and dilution. Preparation Instructions for Bolus Injection and Continuous Infusion
- [PDF]
Bivalirudin
Bivalirudin for Injection is for intravenous Bivalirudin for Injection has been studied only in patients receiving concomitant aspirin. The recommended dose of Bivalirudin for Injection is an intravenous (IV) bolus dose of 0.75 mg/kg, followed immediately by an infusion of 1.75 mg/kg/h for the dura-tion of the procedure. Five minutes after
HIGHLIGHTS OF PRESCRIBING INFORMATION - Pfizer
Bivalirudin for Injection is supplied as a sterile, lyophilized powder in a single-dose, glass vials. Each vial contains 250 mg of bivalirudin equivalent to an average of 275 mg of bivalirudin trifluoroacetate3.
Bivalirudin Monograph for Professionals - Drugs.com
2023年12月5日 · Used as an anticoagulant in patients undergoing percutaneous coronary intervention (PCI), including those with heparin-induced thrombocytopenia (HIT) or heparin-induced thrombocytopenia and thrombosis syndrome (HITTS). Parenteral anticoagulant is recommended in all patients undergoing PCI to prevent thrombus formation during the procedure.
Bivalirudin (Angiomax) (Bivalirudin Injection): Side Effects ... - RxList
2022年9月15日 · Bivalirudin for Injection is supplied as a sterile, lyophilized powder in single-dose, glass vials. Each vial contains 250 mg of bivalirudin equivalent to an average of 270 mg of bivalirudin trifluoroacetate*.
Bivalirudin: Blood Thinning Uses, Side Effects, Dosage - MedicineNet
2024年1月24日 · Bivalirudin is used to prevent blood clotting and obstructing blood flow during PCI procedure with the catheter and the stent placement. Bivalirudin prevents blood clotting by inhibiting thrombin, an enzyme in blood that is involved in the blood-clotting process.
2023年5月9日 · Bivalirudin Injection is indicated for use as an anticoagulant in patients undergoing percutaneous coronary intervention (PCI), including patients with heparin-induced thrombocytopenia and...
- 某些结果已被删除